Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment.

Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Nov 2009

Arca M, Cambuli V M, Montali A, Sentinelli F, Filippi E, Campagna F, Quagliarini F, Antonini R, Romeo S, Baroni M G

Abstract excerpt

BACKGROUND AND AIMS: Hypoadiponectinemia has been reported in patients with familial combined hyperlipidemia (FCHL) presenting increased waist circumference and insulin resistance. However, no studies have evaluated this association in non-obese FCHL patients. Moreover, it is unclear whether correction of lipoprotein abnormalities may influence adiponectin levels in FCHL. METHODS AND RESULTS: We have compared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Atorvastatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heptanoic Acids

Share to Hyperlipidemia, Familial Combined

Share to Hypolipidemic Agents

Share to Pyrroles

Share to Randomized Controlled Trials as Topic

Share to Waist Circumference

Source

Identifiers

PMID: 19632099
DOI: 10.1016/j.numecd.2008.11.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment.PMID 19632099Read ↗

Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile.Semantic proximity Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.Semantic proximity Read ↗

Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.Semantic proximity Read ↗

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.Semantic proximity Read ↗

Combined hyperlipidemia: familial but not (usually) monogenic.Semantic proximity Read ↗

Genetics of familial combined hyperlipidemia.Semantic proximity Read ↗

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.Semantic proximity Read ↗

Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.Semantic proximity Read ↗

Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.Semantic proximity Read ↗

Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.Semantic proximity Read ↗

Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.